Moderna, Inc. (MRNA)

152,10 -2,42 (-1,57%) Al cierre: 04:00PM EDT

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 3900

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Noubar B. Afeyan Ph.D.	Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board	151,84k	N/A	1963
Mr. Stephane Bancel	CEO & Director	4,97M	392,58M	1973
Dr. Stephen Hoge M.D.	Pres	2,41M	56,52M	1976
Mr. James M. Mock	Chief Financial Officer	1,49M	N/A	1977
Mr. Juan Andres	Pres of Strategic Partnerships & Enterprise Expansion	1,28M	11,47M	1966
Ms. Arpa Garay	Chief Commercial Officer	2,67M	N/A	1979
Dr. Jerh Collins Ph.D.	Chief Technical Operations & Quality Officer	N/A	N/A	N/A
Dr. Melissa J. Moore Ph.D.	Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Brad Miller	Chief Information Officer	N/A	N/A	N/A
Ms. Lavina Talukdar CFA	Sr. VP & Head of Investor Relations	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Moderna, Inc., a día 1 de marzo de 2023, es 10. Las puntuaciones base son Auditoría: 10; Tablero: 10; Derechos de los accionistas: 10; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.